Table 1.
Participant characteristics by viral load status, North West Province, South Africa, 2014a
| Not Suppressed (≥ 5000 copies/ml) wgt n = 7981 |
Suppressed (< 5000 copies/ml) wgt n = 4976 |
||||
|---|---|---|---|---|---|
| wgt % | 95% CI | wgt % | 95% CI | P-value | |
| Overall | 61.6 | (51.4–70.9) | 38.4 | (29.2–48.6) | |
| Sex | |||||
| Male | 51.1 | (41.0–61.1) | 21.1 | (10.4–38.2) | 0.003 |
| Female | 48.9 | (38.9–59.1) | 78.9 | (61.8–89.6) | |
| Age group | |||||
| 18–29 Years | 22.2 | (11.4–38.7) | 19.0 | (9.2–35.1) | 0.868 |
| 30–39 Years | 45.0 | (31.0–59.9) | 42.7 | (28.1–58.7) | |
| 40–49 Years | 32.8 | (22.1–45.6) | 38.3 | (24.5–54.4) | |
| Education | |||||
| Primary or Less | 30.2 | (20.3–42.4) | 35.3 | (21.6–52.0) | 0.759 |
| Some Secondary | 39.3 | (30.0–49.5) | 39.8 | (28.0–53.0) | |
| Completed Secondary | 30.5 | (22.2–40.2) | 24.8 | (13.2–41.8) | |
| Prior knowledge of HIV serostatusb | |||||
| Known Positive | 54.2 | (41.7–66.1) | 86.0 | (68.6–94.6) | 0.005 |
| Unknown | 45.8 | (33.9–58.3) | 14.0 | (5.4–31.4)e | |
| ART initiationb | |||||
| No | 19.7 | (10.4–34.3) | 4.8 | (1.4–15.1) | 0.040 |
| Yes | 80.3 | (65.7–89.6) | 95.3 | (85.0–98.6) | |
| Time on ARTb | |||||
| < 1 year | 23.4 | (14.4–35.9) | 13.8 | (7.4–24.3) | 0.134 |
| 1–3 years | 42.9 | (29.4–57.5) | 33.7 | (18.7–52.8) | |
| > 3 years | 33.7 | (21.9–48.0) | 52.5 | (30.8–58.5) | |
| Analytes foundc | |||||
| Yes | 33.3 | (25.3–42.4) | 75.5 | (57.9–87.4) | < 0.001 |
| No | 66.7 | (57.6–74.7) | 24.5 | (12.6–42.2) | |
| CD4 category (Pima)d | |||||
| ≤ 350 cells/μL | 57.8 | (42.8–71.5) | 28.2 | (15.7–45.2) | 0.018 |
| > 350 cells/μL | 42.2 | (28.6–57.2) | 71.9 | (54.8–84.3) | |
aWeights account for sampling, non-response, and age/sex of target population
bBased on self-report
cAssessed for EFV, LPV, NVP
dAmong those for whom Pima CD4 results were available
eRespondents may be mis-reporting status, be elite controllers, or on ART without understanding of their condition [35]